.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Chronic limb-threatening ischemia (CLTI) poses a significant challenge for clinicians managing elderly patients. Choosing between Surgical vs Endovascular Revascularisation remains a pivotal clinical decision. A recent post hoc analysis of the landmark BEST-CLI trial provides fresh insights into how frailty influences these critical treatment outcomes.
The study analyzed 1,754 patients using a deficit-accumulation frailty index. Severe frailty, defined as an index of 0.45 or higher, affected nearly half the participants. Frailty was linked to a higher risk of major adverse limb events (MALE) or death. However, it did not alter the comparative effectiveness of the treatment strategies.
Consequently, surgical bypass remained superior for patients with an adequate great saphenous vein (GSV). Moreover, surgical bypass reduced the risk of MALE or death in both frail and non-frail patients. Specifically, the hazard ratio for both groups was identical at 0.68. This suggests that frailty should not deter clinicians from choosing surgical bypass when a suitable vein conduit is available.
Conversely, outcomes in Cohort 2, which included patients requiring alternative conduits, were similar across all frailty levels. Additionally, researchers found no significant interaction between frailty and major adverse cardiovascular events (MACE). Therefore, clinicians should prioritize vein availability over frailty when deciding the optimal revascularization approach for CLTI patients.
Yes, severe frailty is associated with a higher incidence of major adverse limb events and mortality, regardless of whether the patient undergoes surgery or endovascular therapy.
The BEST-CLI analysis suggests that for patients with a suitable great saphenous vein, surgical bypass is more effective than endovascular therapy. This benefit remains consistent regardless of the patient's frailty status.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
Ko D et al. Frailty and the Efficacy and Safety of Surgical vs Endovascular Revascularisation: A Post Hoc Analysis of the BEST-CLI Trial. Br J Surg. 2026 Jun 02. doi: undefined. PMID: 42227206.
Farber A, et al. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. N Engl J Med. 2022;387(25):2305-2316.
Conte MS, et al. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. J Vasc Surg. 2019;69(6S):1S-125S.e40.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Severe frailty increases risk in CLTI, but surgical bypass remains more effective than endovascular therapy for patients with a suitable vein conduit....
5 months ago
A prospective multicenter cohort study demonstrates that baseline health-related quality of life, particularly physical functioning, independently predicts all-cause maintenance hemodialysis mortality. Assessing patient-reported outcomes provides vital prognostic value beyond standard biochemical markers.
Today
Delhi is undergoing a major healthcare overhaul with enhanced Ayushman Bharat insurance up to ₹10 lakh, increased MBBS and PG medical training seats, expanded primary network mandirs, new tertiary neuro-ICUs, and public-private reproductive technology initiatives to build a resilient, preventative healthcare model.
Today
Aon forecasts India's healthcare inflation will ease to 10.1% in 2027 from 11.5% in 2026. Despite moderation, healthcare expenses continue to outpace general inflation, propelled by non-communicable diseases, advanced medical therapeutics, and expanding utilization patterns across diverse patient populations.
Today
Non-union fractures occur in 2-5% of cases, causing significant disability and cost. Conservative modalities such as LIPUS, PEMF, and focused ESWT offer non-surgical healing options for defects up to 5-10 mm when adequate mechanical stability exists without infection.
Today
Explore how novel oxygen-releasing PVA hydrogels prevent early post-transplant hypoxic damage in pancreatic beta cells, sustaining viability and insulin secretory function.
Today
